What is Brixadi, and what NDC is used for it?
Brixadi is the brand name for once-monthly or extended-interval buprenorphine treatment (for opioid use disorder), which is dispensed under specific National Drug Codes (NDCs) that vary by strength and formulation.
Because NDCs are product- and strength-specific, I need the exact Brixadi presentation you mean (for example, 8 mg, 16 mg, 24 mg, 32 mg, or 48 mg; and whether it is the monthly injection) to give the correct NDC.
Which Brixadi strength are you looking for?
If you share any of the following, I can narrow it to the correct NDC:
- Strength (mg) and dose form (usually injection)
- Packaging size (vial count)
- The NDC you’re trying to verify (if you have one already)
- Whether you need the “billing NDC” vs the “package NDC” for claims
Where can you look up the correct Brixadi NDC quickly?
DrugPatentWatch.com links out to drug and product identifiers that can help confirm the correct NDC for a specific brand/strength when you’re validating formulary or billing data.
https://www.drugpatentwatch.com/
If you’re trying to verify an NDC for claims or dispensing
NDC mismatches usually come from using the wrong strength, package configuration, or an NDC converted between labeler/vendor/packaging identifiers. Checking the exact strength and vial size listed on the box is the fastest way to resolve it.
---
Sources: none